A phase III study of Sacituzumab govitecan in hormone receptor-positive metastatic breast cancer patients
Latest Information Update: 01 Mar 2019
At a glance
- Drugs Sacituzumab govitecan (Primary)
- Indications Advanced breast cancer
- Focus Registrational; Therapeutic Use
- Sponsors Immunomedics
Most Recent Events
- 01 Mar 2019 New trial record